Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Melphalan in Veterinary Oncology: Cumulative Marrow-Risk Discussion
Melphalan is an alkylating antineoplastic medicine used in selected veterinary cancers and requires individualized blood-count, gastrointestinal, and handling plans.
Read more
Mitoxantrone in Veterinary Oncology: Infusion and Blood-Count Profile
Mitoxantrone is an intravenous antineoplastic medicine used in selected canine and feline protocols, with infusion, marrow, and gastrointestinal monitoring.
Read moreGemcitabine in Veterinary Oncology: Limited and Protocol-Specific Evidence
Gemcitabine is an intravenous antimetabolite considered in selected veterinary protocols, where evidence and toxicity must be reviewed for the exact diagnosis.
Read moreMethotrexate in Veterinary Oncology: Interaction and Organ-Safety Review
Methotrexate is a folate-antagonist antimetabolite with selected veterinary uses and clinically important marrow, gastrointestinal, liver, lung, and interaction considerations.
Read moreCytarabine in Veterinary Cancer Care: Route and Marrow Monitoring
Cytarabine is an antimetabolite used in selected veterinary hematologic or central nervous system protocols, with route- and schedule-specific monitoring.
Read moreTaxane Chemotherapy: Formulation, Infusion, and Evidence Questions
Taxanes disrupt microtubule dynamics, but formulation, infusion reactions, species experience, and veterinary evidence differ enough that product names are not interchangeable.
Read more
Metronomic Chemotherapy: Goal, Evidence, and Handling Boundary
Metronomic therapy uses regularly scheduled cytotoxic medication in selected plans; it remains prescription hazardous-drug treatment and is not simply gentle chemotherapy.
Read moreL-Asparaginase in Lymphoid Cancer Protocols
L-asparaginase is an enzyme-based antineoplastic used in selected lymphoma or leukemia protocols, with hypersensitivity and protocol-timing considerations.
Read moreNamed profile Tanovea (Rabacfosadine): FDA-Approved Injectable Canine Lymphoma TherapyRepresentative category illustration – no product packaging is shown.Tanovea (Rabacfosadine): FDA-Approved Injectable Canine Lymphoma Therapy
Rabacfosadine is a canine lymphoma drug whose current official label, patient selection, cumulative risks, and availability must be verified before use.
Read moreCisplatin in Dogs: Species-Specific and Kidney-Safety Boundary
Cisplatin is a platinum chemotherapy used only in carefully selected veterinary settings; it has major kidney, gastrointestinal, infusion, and species-specific hazards.
Read moreHome Handling of Oral Chemotherapy and Patient Waste
Families need drug-specific written instructions for receiving, storing, administering, cleaning, laundering, and disposing of chemotherapy and contaminated patient waste.
Read more
Named profile Canalevia-CA1 (Crofelemer): Chemotherapy-Induced Diarrhoea SupportRepresentative category illustration – no product packaging is shown.Canalevia-CA1 (Crofelemer): Chemotherapy-Induced Diarrhoea Support
crofelemer delayed-release tablets is covered as prescription antisecretory gastrointestinal medicine; supportive care, not antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more